In our study, we investigated the expression of HJURP in 127 CCA patients comprising 32 iCCAs, 71 pCCAs, and 24 dCCAs with immunohistochemistry (IHC) and divided these patients into subgroups with a low or high expression of HJURP. This evidence concerns the gene HJURP and cholangiocarcinoma.